Transcenta Holding

A Global Fully Integrated Biotherapeutics Company

China · Founded 2013 · $205.0M raised

Founded
2013
Business Model
B2B
Total Funding
$205.0M
Last Round
$105.0M Venture RoundDec 2020
Rounds
3

About

Transcenta is a global, fully integrated biotherapeutics company spanning antibody discovery, translational research, process development, clinical development, and manufacturing. Its antibody generation platform is based on Immune Tolerance Breaking Technology, producing therapeutic candidates with differentiated biological profiles. Translational research generates PK, PD, toxicology, and immunogenicity data to model clinical responses and guide trial design. Clinical development spans centers in Beijing, Shanghai, Guangzhou, and Princeton, US, supported by a flexible modular manufacturing facility using classical fed-batch and perfusion-based continuous bioprocessing.

Summary

Transcenta Holding is a Biotech company based in China, founded in 2013. It has raised $205.0M in total across 3 rounds, most recently a $105.0M Venture Round round in Dec 2020. Investors include ARCH Venture Partners, China Structural Reform Fund and Country Garden Venture Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundDec 2020
$105.0M

Sign up to see all 3 rounds

Series B through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Transcenta Holding on Indexed.vc
<a href="https://indexed.vc/companies/transcenta-holding"><img src="https://indexed.vc/api/badge/company/transcenta-holding" alt="Transcenta Holding on Indexed.vc" width="260" height="76" /></a>